Authors:
Fahy, JV
Boushey, HA
Lazarus, SC
Mauger, EA
Cherniack, RM
Chinchilli, VM
Craig, TJ
Drazen, JM
Ford, JG
Fish, JE
Israel, E
Kraft, M
Lemanske, RF
Martin, RJ
McLean, D
Peters, SP
Sorkness, C
Szefler, SJ
Citation: Jv. Fahy et al., Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study, AM J R CRIT, 163(6), 2001, pp. 1470-1475
Authors:
Mikus, LD
Rosenthal, LA
Sorkness, RL
Lemanske, RF
Citation: Ld. Mikus et al., Reduced interferon-gamma secretion by natural killer cells from rats susceptible to postviral chronic airway dysfunction, AM J RESP C, 24(1), 2001, pp. 74-82
Authors:
Israel, E
Drazen, JM
Liggett, SB
Boushey, HA
Cherniack, RM
Chinchilli, VM
Cooper, DM
Fahy, JV
Fish, JE
Ford, JG
Kraft, M
Kunselman, S
Lazarus, SC
Lemanske, RF
Martin, RJ
McLean, DE
Peters, SP
Silverman, EK
Sorkness, CA
Szefler, SJ
Weiss, ST
Yandava, CN
Citation: E. Israel et al., Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma, INT A AL IM, 124(1-3), 2001, pp. 183-186
Authors:
Lazarus, SC
Boushey, HA
Fahy, JV
Chinchilli, VM
Lemanske, RF
Sorkness, CA
Kraft, M
Fish, JE
Peters, SP
Craig, T
Drazen, JM
Ford, JG
Israel, E
Martin, RJ
Mauger, EA
Nachman, SA
Spahn, JD
Szefler, SJ
Citation: Sc. Lazarus et al., Long-acting beta(2)-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma - A randomized controlled trial, J AM MED A, 285(20), 2001, pp. 2583-2593
Authors:
Lemanske, RF
Sorkness, CA
Mauger, EA
Lazarus, SC
Boushey, HA
Fahy, JV
Drazen, JM
Chinchilli, VM
Craig, T
Fish, JE
Ford, JG
Israel, E
Kraft, M
Martin, RJ
Nachman, SA
Peters, SP
Spahn, JD
Szefler, SJ
Citation: Rf. Lemanske et al., Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol - A randomized controlled trial, J AM MED A, 285(20), 2001, pp. 2594-2603
Authors:
Leone, FT
Mauger, EA
Peters, SP
Chinchilli, VM
Fish, JE
Boushey, HA
Cherniack, RM
Drazen, JM
Fahy, JV
Ford, J
Israel, E
Lazarus, SC
Lemanske, RF
Martin, RJ
McGeady, SJ
Sorkness, C
Szefler, SJ
Citation: Ft. Leone et al., The utility of peak flow, symptom scores, and beta-agonist use as outcome measures in asthma clinical research, CHEST, 119(4), 2001, pp. 1027-1033
Authors:
Israel, E
Drazen, JM
Liggett, SB
Boushey, HA
Cherniack, RM
Chinchilli, VM
Cooper, DM
Fahy, JV
Fish, JE
Ford, JG
Kraft, M
Kunselman, S
Lazarus, SC
Lemanske, RF
Martin, RJ
McLean, DE
Peters, SP
Silverman, EK
Sorkness, CA
Szefler, SJ
Weiss, ST
Yandava, CN
Citation: E. Israel et al., The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma, AM J R CRIT, 162(1), 2000, pp. 75-80
Authors:
Sorkness, RL
Mehta, H
Kaplan, MR
Miyasaka, M
Hefle, SL
Lemanske, RF
Citation: Rl. Sorkness et al., Effect of ICAM-1 blockade on lung inflammation and physiology during acuteviral bronchiolitis in rats, PEDIAT RES, 47(6), 2000, pp. 819-824
Citation: Rl. Sorkness et al., Prevention of chronic postbronchiolitis airway sequelae with IFN-gamma treatment in rats, AM J R CRIT, 160(2), 1999, pp. 705-710